The weekly litigation news digest is live. Subscribe now

Patent Oppositions in nervous system drugs industry

Explore the competitive field of nervous system drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in nervous system drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for nervous system drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the nervous system drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the nervous system drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Nov 20, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name
Nutritional CompositionNUTRICIASep 23, 2025NESTLE
Nutritional CompositionNUTRICIASep 22, 2025ABBOTT
System And Method For Genome EditingINSTITUTE OF ZOOLOGYSep 11, 2025STRAWMAN
Solid Oral Formulation Of FenretinideLAURENT PHARMACEUTICALSSep 9, 2025WUESTHOFF & WUESTHOFF
Excipients For Nicotine-Containing Therapeutic CompositionsMODORAL BRANDSSep 2, 2025PHILIP MORRIS
Method For Treating Multiple SclerosisF HOFFMANN LA ROCHEAug 27, 2025GRUNECKER PATENT UND RECHTSANWALTE PARTG MBB
Method For Treating Multiple SclerosisF HOFFMANN LA ROCHEAug 26, 2025POLPHARMA BIOLOGICS
Preparation Containing Tetracyclic Compound At High DoseCHUGAI SEIYAKU KABUSHIKI KAISHAAug 20, 2025ELKINGTON AND FIFE
Preparation Containing Tetracyclic Compound At High DoseCHUGAI SEIYAKU KABUSHIKI KAISHAAug 19, 2025TEVA PHARMACEUTICALS
Use Of Migalostat In Reducing The Risk Of Cerebrovascular Event In Patients With Fabry DiseaseAMICUS THERAPEUTICSAug 13, 2025BRAND MURRAY FULLER

To stay ahead in the competitive nervous system drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the nervous system drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleApplicantTotal Oppositions
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA20
Dec 6, 2023Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICALS9
Apr 22, 2020Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICALS9
Jul 15, 2020Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep InhibitorNOVARTIS8
Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS8
Jun 30, 2021Method For Treating Primary InsomniaNEURIM PHARMACEUTICALS7
Apr 10, 2019Dosage Form Containing Oxycodone And NaloxoneEURO CELTIQUE7
Oct 9, 2024Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICAL7
Jan 4, 2017Low Frequency Glatiramer Acetate TherapyYEDA RESEARCH6
Nov 27, 2024Method For Treating Multiple SclerosisF HOFFMANN LA ROCHE6